Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics

4, 4'-Dihydroxybenzophenone-2, 4-dinitrophenylhydrazone (A-007) has recently completed a phase-I clinical trial, and objective responses were seen in advanced breast cancer, lung cancer, ovarian cancer, melanoma, skin cancer and non-Hodgkin's lymphoma. Despite the promising results in the...

Full description

Bibliographic Details
Main Author: Sagiraju, Sarada
Format: Others
Published: ScholarWorks@UNO 2008
Subjects:
Online Access:http://scholarworks.uno.edu/td/900
http://scholarworks.uno.edu/cgi/viewcontent.cgi?article=1881&context=td
id ndltd-uno.edu-oai-scholarworks.uno.edu-td-1881
record_format oai_dc
spelling ndltd-uno.edu-oai-scholarworks.uno.edu-td-18812016-10-21T17:04:51Z Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics Sagiraju, Sarada 4, 4'-Dihydroxybenzophenone-2, 4-dinitrophenylhydrazone (A-007) has recently completed a phase-I clinical trial, and objective responses were seen in advanced breast cancer, lung cancer, ovarian cancer, melanoma, skin cancer and non-Hodgkin's lymphoma. Despite the promising results in the clinical trials, the major disadvantage to using A-007 as a broad-scale therapeutic is its poor water solubility. To make use of this promising anticancer drug either orally or intravenously, the short-term obstacle must be to overcome the limited solubility of A-007 in water. There are several approaches to overcome this obstacle. The first approach is to make hydrolysable prodrugs of A-007. The second approach is to make an A-007 complex with a water soluble host, such as cyclodextrin. We used a combination of these two previously described methods, i.e. transforming A-007 into a more water soluble prodrugs and then further increasing the prodrug water solubility by making their cyclodextrin inclusion complexes. Our syntheses and spectroscopic explorations of A-007 prodrugs are presented in this dissertation. Tetramic acid (2, 4 pyrrolidine-2, 4-dione ring system) containing compounds have been found to display a remarkable diversity of biological activities and have attracted the interest of medicinal and synthetic chemists. Magnesidin (1-acetyl-3-octanoyl-5-ethylidene tetramic acid) has strong antimicrobial activity against bacteria that cause gingivitis and dental plaque. Current efforts toward the synthesis of Magnesidin are discussed along with the plans for the completion of synthesis. 2008-12-19T08:00:00Z text application/pdf http://scholarworks.uno.edu/td/900 http://scholarworks.uno.edu/cgi/viewcontent.cgi?article=1881&context=td University of New Orleans Theses and Dissertations ScholarWorks@UNO Cancer Cyclodextrin Inclusion complexes A-007 prodrugs Molecular aggregation NOESY ES mass spectroscopy azlactone condensation azlactone ring opening oxazolones tetramic acids Magnesidin
collection NDLTD
format Others
sources NDLTD
topic Cancer
Cyclodextrin
Inclusion complexes
A-007 prodrugs
Molecular aggregation
NOESY
ES mass spectroscopy
azlactone condensation
azlactone ring opening
oxazolones
tetramic acids
Magnesidin
spellingShingle Cancer
Cyclodextrin
Inclusion complexes
A-007 prodrugs
Molecular aggregation
NOESY
ES mass spectroscopy
azlactone condensation
azlactone ring opening
oxazolones
tetramic acids
Magnesidin
Sagiraju, Sarada
Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics
description 4, 4'-Dihydroxybenzophenone-2, 4-dinitrophenylhydrazone (A-007) has recently completed a phase-I clinical trial, and objective responses were seen in advanced breast cancer, lung cancer, ovarian cancer, melanoma, skin cancer and non-Hodgkin's lymphoma. Despite the promising results in the clinical trials, the major disadvantage to using A-007 as a broad-scale therapeutic is its poor water solubility. To make use of this promising anticancer drug either orally or intravenously, the short-term obstacle must be to overcome the limited solubility of A-007 in water. There are several approaches to overcome this obstacle. The first approach is to make hydrolysable prodrugs of A-007. The second approach is to make an A-007 complex with a water soluble host, such as cyclodextrin. We used a combination of these two previously described methods, i.e. transforming A-007 into a more water soluble prodrugs and then further increasing the prodrug water solubility by making their cyclodextrin inclusion complexes. Our syntheses and spectroscopic explorations of A-007 prodrugs are presented in this dissertation. Tetramic acid (2, 4 pyrrolidine-2, 4-dione ring system) containing compounds have been found to display a remarkable diversity of biological activities and have attracted the interest of medicinal and synthetic chemists. Magnesidin (1-acetyl-3-octanoyl-5-ethylidene tetramic acid) has strong antimicrobial activity against bacteria that cause gingivitis and dental plaque. Current efforts toward the synthesis of Magnesidin are discussed along with the plans for the completion of synthesis.
author Sagiraju, Sarada
author_facet Sagiraju, Sarada
author_sort Sagiraju, Sarada
title Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics
title_short Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics
title_full Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics
title_fullStr Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics
title_full_unstemmed Synthesis and Spectroscopic Study of Anticancer agent A-007 Prodrugs and Progress Towards the Synthesis of Tetramic acid Antibiotics
title_sort synthesis and spectroscopic study of anticancer agent a-007 prodrugs and progress towards the synthesis of tetramic acid antibiotics
publisher ScholarWorks@UNO
publishDate 2008
url http://scholarworks.uno.edu/td/900
http://scholarworks.uno.edu/cgi/viewcontent.cgi?article=1881&context=td
work_keys_str_mv AT sagirajusarada synthesisandspectroscopicstudyofanticanceragenta007prodrugsandprogresstowardsthesynthesisoftetramicacidantibiotics
_version_ 1718388030424743936